Drug intelligence / Profile preview

exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1

Development stage
Unknown
Lead developer
Meiji
Administration
Oral
01

Overview

Exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 (R-1 EPS) are natural immunomodulatory biologic compounds produced by a specific lactic acid bacterial strain. Composed of neutral and acidic polysaccharides (glucose and galactose), R-1 EPS functions as an immunomodulator that enhances host innate immunity by activating natural killer (NK) cells and inducing proinflammatory cytokines. Beyond innate immunity, R-1 EPS has been shown to modulate adaptive immune responses by inducing CCR6+ CD4+ T cells (Th7R) in Peyer's patches, which can enhance the antitumor efficacy of immune checkpoint inhibitors like PD-1/PD-L1 blockades. It is widely utilized as a functional ingredient in yogurt products to reduce the risk of the common cold and is being investigated for its potential to augment immunotherapy in cancer patients, particularly those with non-small cell lung cancer (NSCLC).

Brand names
Meiji Probio Yogurt R-1
Other names
Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1 exopolysaccharides
02

Targets

CCR6 (C-C motif chemokine receptor 6)LPAR5 (Lysophosphatidic acid receptor 5)

Beyond the preview

Go deeper on exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on exopolysaccharides from Lactobacillus delbrueckii ssp. bulgaricus OLL1073R-1.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call